Eterna Therapeutics
ERNA
#11154
Rank
ยฃ2.1 M
Marketcap
ยฃ1.24
Share price
0.62%
Change (1 day)
16.90%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2026 (TTM): -ยฃ21.67

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ22.35. In 2022 the company made an earnings per share (EPS) of -ยฃ2,401 an increase over its 2021 EPS that were of -ยฃ15,863.

EPS history for Eterna Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ21.67
2022-ยฃ2,401-84.86%
2021-ยฃ15,863

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
ยฃ1.51-106.76%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-ยฃ1.08-95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
ยฃ1.31-105.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-ยฃ0.06105-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
ยฃ0.34-101.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
ยฃ0.89-103.99%๐Ÿ‡บ๐Ÿ‡ธ USA